Development of lipid nanoparticles for transdermal loteprednol etabonate delivery.
Burcu ÜnerSamet ÖzdemirÇetin TaşYıldız ÖzsoyMelike ÜnerPublished in: Journal of microencapsulation (2022)
SLN and NLC formulations of LE can be stated among the systems that can be an alternative to conventional systems with fewer side-effects in the treatment of inflammatory problems.